D-0058-2021 Class II Terminated

Recalled by Direct Rx — Dawsonville, GA

FDA drug recall D-0058-2021 was initiated by Direct Rx on Oct 12, 2020 and is designated Class II. Reason for recall: CGMP Deviations: detection of N-Nitrosodimethylamine (NDMA) impurity above the acceptable intake level (per manufacturer) The recall status is terminated (terminated Sep 22, 2021). Affected quantity: 88 bottles.

Recall details

Product Type
Drugs
Report Date
Nov 11, 2020
Initiation Date
Oct 12, 2020
Termination Date
Sep 22, 2021
Voluntary/Mandated
Voluntary: Firm initiated
Product Quantity
88 bottles

Product description

Metformin HCL E/R 500 mg, 90 Tabs, Packaged and Distributed By: Direct Rx Dawsonville, GA 30534 NDC 72189-064-90

Reason for recall

CGMP Deviations: detection of N-Nitrosodimethylamine (NDMA) impurity above the acceptable intake level (per manufacturer)

Distribution pattern

FL

Code information

Lot: 04DE1902, 11DE1908 Exp. 06/30/2021

Source

Dataset
openFDA drug recall enforcement reports
FDA record
This recall in openFDA (JSON)
Enforcement Report
Search FDA's Enforcement Report for D-0058-2021
openFDA file date
Nov 10, 2026
Loaded by RegDataLab
Nov 11, 2026

These dates say when openFDA published the data file and when RegDataLab last loaded it.

Source: openFDA record for D-0058-2021. Report a data issue: hello@regdatalab.com.